# Master Performance Report & Investment Committee Review

This report consolidates the findings from the Stage 7 robust audits and presents the final deployable verdict for the production multi-factor model.

## 1. Investment Committee Threshold Table

| Test | Threshold | Result | Pass? |
| :--- | :---: | :---: | :---: |
| Baseline Sharpe | >0.50 | 0.1498 | **FAIL** |
| PBO | <20% | 25.0000 | **FAIL** |
| DSR | >0.80 | 0.4033 | **FAIL** |
| IR | >0.20 | 0.0419 | **FAIL** |
| Top5 Removed Sharpe | >0.40 | -0.1749 | **FAIL** |
| Double Cost Sharpe | >0.40 | -0.1553 | **FAIL** |
| Delay Execution Sharpe | >0.40 | 0.1638 | **FAIL** |
| IT Removed Sharpe | >0.30 | 0.3389 | **PASS** |
| Banking Removed Sharpe | >0.30 | 0.2642 | **FAIL** |

## 2. Deployment Decision Framework

-   **Critical Failures Detected**: **1** (Top-5 Winner Removal Sharpe Decay > 50%)
-   **Minor Failures Detected**: **8**
    *   Baseline Sharpe fails >0.50 (Actual: 0.1498)
    *   PBO fails <20% (Actual: 25.0)
    *   DSR fails >0.80 (Actual: 0.4033)
    *   IR fails >0.20 (Actual: 0.0419)
    *   Top5 Removed Sharpe fails >0.40 (Actual: -0.1749)
    *   Double Cost Sharpe fails >0.40 (Actual: -0.1553)
    *   Delay Execution Sharpe fails >0.40 (Actual: 0.1638)
    *   Banking Removed Sharpe fails >0.30 (Actual: 0.2642)

> [!CAUTION]
> **FINAL STATUS VERDICT**: **RED**
> **RECOMMENDED ACTION**: **Freeze development and rebuild.**

## 3. Deployment Review Summary

*   **Alpha Dependency**: The strategy has a critical dependency on a very small set of tickers. Removing the top 5 winners results in a **216.7%** drop in Sharpe, leading to negative performance. This fails the institutional concentration limits.
*   **Backtest Overfitting**: Combinatorial Cross-Validation shows a PBO of **25.00%**, indicating concerns about backtest overfitting. The Deflated Sharpe Ratio of **0.4033** is below the 0.80 target, indicating significant multiple testing drag.
*   **Transaction Costs**: The model is highly sensitive to transaction costs. Applying double variable transaction costs drops the Sharpe ratio below the target threshold, indicating capacity limits.

---

## 4. Final Verification Status

The research stage is complete. While the multi-factor scoring engine identifies statistically significant signals, the final portfolio implementation fails to meet the required risk-adjusted consistency and concentration thresholds. Live execution capital should not be deployed under this configuration.